Machine Learning and Deep Learning in Drug Design
Royal Society of Chemistry
ISBN 978-1-83707-018-3
Standardpreis
Bibliografische Daten
Buch. Hardcover
2026
Umfang: 772 S.
Format (B x L): 15.6 x 23.4 cm
Verlag: Royal Society of Chemistry
ISBN: 978-1-83707-018-3
Weiterführende bibliografische Daten
Das Werk ist Teil der Reihe: Drug Discovery Series
Produktbeschreibung
Machine learning (ML) and deep learning (DL) are reshaping the landscape of drug design. This comprehensive volume explores how these technologies are applied across the entire drug discovery pipeline--from target identification and protein structure prediction to virtual screening, pharmacokinetic modelling, and drug repurposing.
Bridging cheminformatics, chemometrics, and computational science, the book offers practical case studies, emerging methodologies, and curated e-resources. Readers will discover how ML/DL techniques are used to predict drug-target interactions, optimize molecular properties, repurpose previously used drugs, and design multi-target therapeutics. Special topics include chemical language models, natural product-based drug discovery, and modelling drug-induced toxicities.
With contributions from leading experts worldwide, this book is an essential resource for researchers, postgraduate students, and professionals in medicinal chemistry, pharmacology, and pharmaceutical sciences. It provides both foundational knowledge and advanced applications, equipping readers to harness AI for innovative and efficient drug development.
Autorinnen und Autoren
Produktsicherheit
Hersteller
Libri GmbH
Europaallee 1
36244 Bad Hersfeld, DE
gpsr@libri.de
BÜCHER VERSANDKOSTENFREI INNERHALB DEUTSCHLANDS
